Circulating miR-148b and miR-652 also might have prognostic capabilities as in cohort B they correlated with the tumor marker p53, whose addition (together with Ki-67) to conventional clinico-pathological characteristics seems to be helpful in the prognostic evaluation of breast cancer [44], [45]. This evidence concerns the gene TP53 and breast carcinoma.